prof marko munjiza

 


V RADOVI OBJAVLJENI KAO SAŽECI NA MEĐUNARODNIM KONGRESIMA I SIMPOZIJUMIMA


a) Časopisi
 r Aadovi objavljeni kao sažeci na međunarodnim kongresima i simpozijumima
95. MUNJIZA M. (1987): Clinical and epidemiological characteristics of affective disorders. XXVII International neuropsychiatric symposium, Pula. Neurologija, Suppl. 1., Vol. 36:197.

96. MUNJIZA M. et al. (1988): Cognitive disfunction in manic disorders. XXVIII International neuropsychiatric symposium, Pula, Neurologija, Suppl. 1., Vol. 37:46-47.

97. MUNJIZA M. (1988): Cognitive disorders as differential diagnostic criterium in incipient psychoses and borderline conditions, XXVIII Intern. neuropsychiatric symposium, Pula, Neurologija, Suppl. 1., Vol. 37:47.

98. MUNJIZA M. (1988): Cognitive disorders in psychosomatic syndrome and therapeutic possibilities, XXVIII International neuropsychiatric symposium, Pula, Neurologija, Suppl. 1., Vol. 37:48.

99. ŠAŠIĆ M., VUKOVIĆ N., MUNJIZA M. et al. (1988): Intelectual defficiencies acute viral encephalitis in childhood and adolescence, XXVIII International neuropsychiatric symposium, Pula, Neurologija, Suppl. 1., Vol. 37:49.

100. ŠAŠIĆ M., VUKOVIĆ N., MUNJIZA M. et al. (1988): Residual cerebral lesion after multiple acute encephalitis in childhood and adolescence, XXVIII International neuropsychiatric symposium, Pula, Neurologija, Suppl. 1., Vol. 37:49-50.

101. ŠAŠIĆ M., VUJOŠEVIĆ M., MUNJIZA M. et al. (1989): Disorders of movement coordination and vertigo after acute viral encephalitis in childhood and adolescence, XXIX International neuropsychiatric symposium, Pula, Neurologija, Suppl. 1., Vol. 38:67.

102. MUNJIZA M. and ŠAŠIĆ M. (1989): Combined therapy in treating somatic depression, XXIX International neuropsychiatric symposium, Pula, Neurologija, Suppl. 1., Vol. 38:12.

103. MUNJIZA M. et al. (1990): TIA and ring in oldre patients, XXX Int. symposium, Pula, Neurologija Suppl. 2, Vol. 39:86.

104. MUNJIZA M. et al. (1990): Haemerriological aspects of prevention and therapy of psychogeriatric disorders, XXX Int. symposium, Pula., Neurologija Suppl. 2, Vol. 39:95-96.

105. MUNJIZA M. (1990): Effects of serotonin uptake inhibitors in panic and obsessive disorders; a double blind comparation of fluoxamine and maprotiline effect, XVII CINP congres, Kyoto. Psychopharmacology, Springer Int. 159.

106. MUNJIZA M. (1990): Haemorrhological aspects of prevention and therapy of cerebrovascular disorders, XVII CINP congres, Kyoto. Psychopharmacology, Springer Int. 438.

107. MUNJIZA M. (1991): Pharmacological therapy of chronic pain, XXXI Int. symposium, Pula, Neurologija Suppl. 2, Vol. 40:78.

108. MUNJIZA M. et al. (1991): The importance of group process and nonverbal communications in rehabilitation of schizophreni, XXXI Int. symposium, Pula, Neurologija Suppl. 2, Vol. 40:84.

109. MUNJIZA M. et al. (1991): Affective disorders and cerebral vascular diseas, Biological psychiatry, Vol. 29, 11S, 1:337-338.

110. MUNJIZA M., ZDRAVKOVIĆ B., ŠAŠIĆ M. (1991): Affective illness and cerebral vascular disease, 5th World Congress of Biological Psychiatry, Florence, Italy, June 9th-14th 1991, Biological Psychiatry, Vol. 29, No. 11S, 337-338.
 
111. MUNJIZA M., ZDRAVKOVIĆ B., ŠAŠIĆ M. (1991): Haemorheological aspects of prevention and therapy of psychogeriatric disorders, 5th World Congress of Biological Psychiatry, Florence, Italy, June 9th-14th 1991. Biological Psychiatry, Vol. 29, No. 11S, 693.

112. RADIVOJEVIĆ V. and MUNJIZA M. (1991): Cognitive evaluation of depressive pseudodementia (DPD), Biological psychiatry, Vol. 29, 11S, 1:699
113. MUNJIZA M. (1994): Antidepressant treatmentt for post-stroke depression, 19th CINP Congress, Washington DC, 27th June-1st July 1994, Psychopharmacotherapy, Springer Int. 1994, pp. 589.

114. MUNJIZA M. (1994): Lack of interaction between disulfiram and moclobemide in alcocholic patients, 19th CINP Congress, Washington DC, 27th June-1st July 1994, Psychopharmacotherapy, Springer Int. 1994, pp. 637.

115. MUNJIZA M., STARČEVIĆ V. (1995): Carbamazepine - use in the treatment of the benzodiazepine withdrawal syndrome, CINP Regional Conference Neurosci Neuropharmacol. in Vienna and Prague, 10-14.VI 1995., Homeostasis in Health Disease, 36, p. 98.

116. MUNJIZA M. (1995): Application of epidemiological methods in studying alcocholism, Regional Symposium of WPA, Prague 20-23. IX 1995., Česka a Slovenska Psychiatrie, Suppl. 2, S 44.

117. MUNJIZA M. (1995): Clinical and epidemiological characteristics of affective psychoses, Regional Symposium of WPA, Prague, 20-23. IX 1995., Česka a Slovenska Psychiatrie, Suppl. 19, S 45.

118. MUNJIZA M. (1995): Depression and suicidal behavior, Regional Symposium of WPA, Prague, 20-23. IX 1995., Ceska a Slovenska Psychiatrie, Suppl. 19 , S 45-46.

119. MUNJIZA M. (1996): Depressive disturbance as a consequence of cerebrovascular disease, 8th Congress of Association of European Psychiatrics, London, 7-12 VII 1996. Eur. Psychiatry Vol. 11, Suppl. 4, p. 393.

120. POPOVIĆ-DEUŠIĆ S., MUNJIZA M. et al. (1997): Follow-up of psychotic children and adolescents, European Congress of the WPA, Geneva, April 23rd-26th, Eur. Psychiatry, 12 (Suppl. 2), 204S.

121. STARČEVIĆ V., KELIN K., MUNJIZA M. (1997): A culture-sensitive screen for neuurasthenia; European Congress of the WPA, Geneva, April 23rd-26th, Eur. Psychiatry 12 (Suppl. 2), (FC 20), p. 164S.
 
122. MUNJIZA M. (1997): The pharmacotherapy of acute confused states; European Congress of the World Psychiatric Association, Geneva, April 23rd-26th 1997. Eur. Psychiatry 12 (Suppl. 2), (P97), 214S.

123. MUNJIZA M., STARČEVIĆ V. (1997): Meteorological factors and anxiety and depression, European Congress of the World Psychiatric Association, Geneva, April 23rd-26th 1997, Eur. Psychiatry 12 (Suppl. 2), (P51), 203S.

124. MUNJIZA M. (1997): Clinical-epidemiological study: Alzheimer and multiinfarct types of dementia; European Congress of the World Psychiatric Association, Geneva, April 23rd-26th 1997, Eur. Psychiatry 12 (Suppl. 2), (P52), 203S.
 
125. MUNJIZA M., POPOVIĆ-DEUŠIĆ S. (1997): Children of manic-depressive parents, European Congress of the World Psychiatric Association, Geneva, April 23rd-26th 1997, Eur. Psychiatry 12 (Suppl. 2), (P168), 231S.

126. LJUBOMIROVIĆ N., MUNJIZA M.   (1998):Pharmacotherapy of child and adolescent depression, Workshop: Novel Therapeutic Strategies in the Schizophrenic Spectrum and Mood Disorders, Venice,Mat 12rd-14th  1998

127. LJUBOMIROVIĆ N., MUNJIZA M. (1997): The therapy of war-traumatized adolescents, J. European Neuropsychopharmacology, vol. 17, suppl. 2: S163.

128. MUNJIZA M., LJUBOMIROVIĆ B. (1997): Pharmacotherapy of pre-menstrual syndrome, J. European Neuropsychopharmacology, vol. 7, suppl. 2: S163.

129. MUNJIZA M. et al (1997): Effects of pharmacotherapy to depression in the period of adolescence, J. European Neuropsychopharmacology, vol. 7, suppl. 2: S261

130. MUNJIZA M.: Pharmacotherapy of depressive disorders in period of involution, J. European Neuropsychopharmacology, vol. 7, suppl. 2: S162.

131. LJUBOMIROVIĆ N, MUNJIZA M., POPOVIĆ-DEUŠIĆ S.(1997): The therapy of wae-traumatized adloescents, J. European Neuropsychopharmacology, vol. 7, suppl. 2: S233

132. MUNJIZA M., LJUBOMIROVIĆ N. (1998): Anxiety of schizophrenia and treatment, Psychiatris Danubina Vol. 10, No. 3, 315, Vienna.

133. LJUBOMIROVIĆ N., MUNJIZA M. (1998): Chronic pain and treatment – case repport, Psychiatria Danubina, Vol. 10, No. 3, 316, Vienna.

134. MUNJIZA M., VELIČKOVIĆ S., MAČKIĆ S., LJUBOMIROVIĆ N. (1998): Pharmacotherapy of depression and chronic pain, The Journal of the Assiociation of European Psychiatrists Vol. 13, Suppl. 4:S317,Copenhagen.

135. MUNJIZA M., MITROVIĆ S., LJUBOMIROVIĆ N. (1998): Pharmacotherapy of elderly patients with cognitive deficiency and/or depression, J. European Neuropsychopharmacology, vol. 8, suppl. 2: S277, Paris.

136. MUNJIZA M et al (2000): Effects oof pharmacotherapy to depression in the period of adolescence, Europen Neuropsychopharmacology, 13th Congress of the European College of neuropsychiatry, Munich septembar 9-13, 2000, European Neuropsychopharmacolog, Vol. 10, Suppl. 3, September, 2000, S261,

137. NIKOLIĆ M, VIDOJEVIĆ P, MUNJIZA M. (2000): The quality in the extended treatment phase with moodstabilizers, Europen Neuropsychopharmacology, 13th Congress of the European College of neuropsychiatry, Munich septembar 9-13, 2000, European Neuropsychopharmacolog, Vol. 10, Suppl. 3, September, 2000, S281 

 

b) Zbornici

138. MUNJIZA M. (1978): L'analyse clinico-epidemiologique du traitement des alcocoliques al' hospital de jour. 32nd International congress on alcoholism and drug dependence, Warsaw, Vol. I:289.

139. MUNJIZA M. (1979): Epidemiološke karakteristike endogenih psihoza u senijumu, XIX internacionalni neuropsihijatrijski simpozijum, Pula, 12-17.VI, 96.

140. MUNJIZA M. (1981): Stanovništvo Beograda pod rizikom od psihoza i neke mogućnosti prevencije, IX Međunarodni kongres preventivne i socijalne medicine, Beograd. Knjiga rezimea, str. 164.

141. MUNJIZA M. (1985): Depresivni pomak kod shizofrenije i mogućnosti lečenja (iskustva sa Cobefrinom), XXV Intern. neuropsihijatrijski simpozijum, Pula, 1-7.VI, 67.

142. MUNJIZA M., ZDRAVKOVIĆ B. (1986): Trental in the treatment of psychogeriatric and cerebrovascular patients, XXVI International neuropsychiatric symposium, Pula, Abstracts book:134.

143. MUNJIZA M. (1986): Clinical epidemiologic characteristics of psychogeriatric disorders in Belgrade, XXVI International neuropsychiatric symposium, Pula, Abstracts book:136-137.

144. MUNJIZA M. (1987): Multidimensional approach to the etiology of psychiatric disturbances, 6th Mediteranean Congress of Social Psychiatry; Mediteranean Sociopsychiatric Association, Zagreb; 1st-4th October; Abstracts book, p. 84-85.

145. MUNJIZA M. (1988: The therapy of organic depression, (P-31.01.03.) XVIth CINP Congress, Munich, 15th-19th August 1988; Abstracts book, p. 260.

146. MUNJIZA M. (1989): Sociopsychiatric characteristics of reactive psychoses, VIII World Congress of Psychiatry, Athens, Eds: Stefanis et al.: Excerpta Medica, Int. Congress series No. 899:437.

147. MUNJIZA M. (1989): The determination of psychiatric disturbances with social factors, VIII World Congress of Psychiatry, Athens, Eds: Stefanis et al.: Excerpta Medica, Int. Congress series No. 899:752.

148. MUNJIZA M. (1990): Cost-benefit analysis of hospital treatment of schizophrenia in Belgrade, First Workshop on cost and Assessment in Psychiatry (The cost of schizophrenia): Venezia, 28-31.X, 51.

149. MUNJIZA M. et al. (1991): Pharmacological therapy of chronic pain, 31st Intern. Neuropsychiatric Symposium in Pula, 26th May-1st June 1991, Proceedings, Eds. Barac B., Lechner H., pp. 122-123.

150. ZDRAVKOVIĆ B., STRIKOVIĆ J., MUNJIZA M., ČIRKOVIĆ M. (1991): Depression as a problem in rehabilitation of patients with cerebrovascular disease, 31st Intern. Neuropsychiatric Symposium in Pula, 26th May-1st June 1991, Proceedings, Eds. Barac B., Lechner H., pp. 122.

151. MUNJIZA M. et al. (1991): The meaning of group process and non-verbal communications in rehabilitation of schizophrenia, 31st Intern. Neuropsychiatric Symposium in Pula, 26th V-1st VI 1991, Proceedings, Eds. Barac B., Lechner H., pp. 101.

152. MUNJIZA M. (1992): The determination of psychiatric disturbances with psychosocial factors, Association of European Psychiatrists (AEP), section committee "Psychiatric Epidemiologic and Social Psychiatry, VIth European Symposium, Zurich, April 8th-10th 1992; Abstracts book, 98.

153. MUNJIZA M. (1992): Semi-hospital treatment of depressive psyvhosis, a cost-benefit analysis, Proceedings of the Third Workshop on cost of affective disorders, Venezia, October 26-28.  1992, pp. 87-88.

154. MUNJIZA M. (1992): Clinical and epidemiological charmacteristics of affective psychoses, Proceedings of the Third Workshop on cost of affective disorders, Venezia, October 26-28.  1992, pp. 88.

155. MUNJIZA M. (1994): Systemic family therapy, antidepressant treatment of alcocholism and quality of life in family, Proceedings off Symposium on Quality of life and disabilities in mental disorders, Wienna, 7-9. IV 1994, pp. 158.

156. MUNJIZA M. (1994): The role of family involvement in the quality of life and social reintegration of schizophrenic patients, Proceedings of Symposium on Quality of life and disabilities in mental disorders, Wienna, 7-9. IV 1994, pp. 159.

157. MUNJIZA M. (1994): Socio-medical aspects of the benzodiazepines (BZD), a cost-benefit analysis, Proceedings of the Third Workshop on cost of affective disorders, Venezia, 26-28. X 1994, pp. 30.

158. MUNJIZA M. (1994):Antidepressant treatment for poststrocke depression, XIXth C.I.N.P.Congersss, Washington, D.C., Collegium Internationale Neuro-Psychopharmacologicum, June 27-July 1, 1994. Abrastacts books

159. MUNJIZA M (1994): Lack of interaction between disulfiram and moclobemid in olcoholic patients, XIXth C.I.N.P.Congersss, Washington, D.C., Collegium Internationale Neuro-Psychopharmacologicum, June 27-July 1, 1994. Abrastacts books

160. MUNJIZA M. (1995): The cost of schizophrenia, Proceedings of Workshop Critical Issues in the treatment of Schizophrenia, Florence 10-12. III 1995.,  pp. 164-165.

161. MUNJIZA M. (1995): Vulnerability of an individual and addiction disorder, First Conference of the Balkan Countries on Alcocholism and drug dependence with int. attendance, 25-28 IX 1995, Belgrade, Summary book, 58.

162. MUNJIZA M. (1995): Depression and alcocholism, First Conference of the Balkan Countries on Alcocholism and drug dependence with int. attendance, Belgrade, 25-28 IX 1995. Summary book, 47.

163. MUNJIZA M. (1995): Moclobemid and maprotiline in chronic neurogenic pain syndromes, First Europe Congess of Paychopharmacology, Milan, Italy, June 16-19, 1995, 798.

164. MUNJIZA M.(1995): Psychotherapeutic agents: antidepresants, First Europe Congess of Paychopharmacology, Milan, Italy, June 16-19, 1995

165. POPOVIĆ-DEUŠIĆ S., STARČEVIĆ V., MUNJIZA M. (1996): Suicide behavior in hospitalized adolescents, 17th Psychiatry Danube Smposium, Timisoara, Romania, 24-27. IV 1996. Abstracts book, p. 50.

166. POPOVIĆ-DEUŠIĆ S., STARČEVIĆ V., MUNJIZA M. (1696): Affective disorders in mentally retarded children and adolescents. 17th Psychiatry Danube Smposium, Timisoara, Romania, 24-27. IV 1996. Abstracts book, p. 58.

167. MUNJIZA M., STARČEVIĆ V., POPOVIĆ-DEUŠIĆ S. (1996): Schizophrenia, pharmacotherapy and psychosocial stress, 17th Psychiatry Danube Smposium, Timisoara, Romania, 24-27. IV 1996. Abstracts book, p. 55

168. STARČEVIĆ V., KELIN K., MUNJIZA M. (1996): Treatment of comorbid atypical depression in patients with agoraphobia and panic disorder; 17th Danube Symposion of Psychiatry, Timisoara, Romania, 24th-27th April 1996; Abstracts book, p. 25.

169. POPOVIĆ-DEUŠIĆ S., MUNJIZA M., STARČEVIĆ V. (1996): Childhood onset schizophrenia as health and soial problem in Yugoslavia; 17th Danube Symposion of Psychiatry, Timisoara Romania, 24th-27th April 1996; Abstracts book, p. 41.

170. MUNJIZA M. et al. (1996): Treatment of social phobia, X World Congress of Psychiatry, Madrid, August 23-28,  1996. Abstracts book Vol. II, p. 271.

171. MUNJIZA M. et al. (1996):Epidemiological reasearch in psychogeriatrics, X World Congress of Psychiatry, Madrid, August 23–28 1996. Abstracts book Vol. II, p. 175.

172. MUNJIZA M. et al. (1996): Application of electroencephalography and the other instruments in evaluation of chronic pain treatmen,. 9th IPEG Symposium, Prague, 12-14. IX 1996., Abstracts book pp. 37.

173. ZDRAVKOVIĆ-MUNJIZA, B., MUNJIZA M. (1996): The combined treatment of chronical pain syndrome with transdermal electrical stimulation (TNS) and psychotherapy, 9th IPEG Symposium, Prague, September 12-14, 1996, Abstract book, pp.59

174. MUNJIZA M. (1996): Possibilities of the pharmacological treatment of depression (introduction lecture, Int. Conference on the therapeutic standards of psychiatric diseases, BPA. Varna, 25-27. X 1996. Abstracts book, pp. 23.

175. MUNJIZA M. (1996): Social-psychiatric characteristics of endoreactive psychoses, Int. Conference on the therapeutic standards of psychiatric diseases, BPA. Varna, 25-27. X 1996. Abstracts book, p. 24.

176. MUNJIZA M. et al. (1996): Course and outcome of the first episode of schizophrenia. I Congress First Psychotic Episode of schizophrenia, Amsterdam 28-29. XI 1996, Abstracts book, p. 47

177. MUNJIZA M. et al. (1996): Multiaxial evaluation of schizoaffective disorders, First Congress Psychotic first episode of schizophrenia, Amsterdam 28-29. XI 1996, Abstracts book, p. P8.

178. MUNJIZA M. et al. (1997): Cost-benefit analysis of intensive combined family therapy for alcochol dependence, Fourth Workshop on cost and assessment in psychiatry, Venice, 14-16 III 1997. Proceedings, Ed. M. Moscorelli, Scuola Grande di San Giovanni Evangeista, Milano Italy, p. 42

179. MUNJIZA M. et al. (1997): Cost/benefit analysis of the program for prevention of addictive, multidrug use behavior with adolescents in Leskovac, Fourth Workshop on cost and assessment in psychiatry, Venice, March 14-16 1997. Proceedings, Ed. M. Moscorelli, Scuola Grande di San Giovanni Evangeista Milano Italy, p 76

180. MUNJIZA M. (1997): Socio-medical aspects of the use of benzodiazepine (BDZ); A cost benefit analysis, Fourth Workshop on cost and assessment in psychiatry, Venice, March 14-16 1997. Proceedings, Ed. M. Moscorelli, Scuola Grande di San Giovanni Evangeista  Milano Italy, p 77

181. MUNJIZA M. (1997): Aplication of epidemiological metods in studing alcoholism, Fourth Workshop on cost and assessment in psychiatry, Venice, March 14-16 1997. Proceedings, Ed. M. Moscorelli, Scuola Grande di San Giovanni Evangeista, Milano Italy, p 78.

182. MUNJIZA M. (1997): A Complex Therapeutic Approach to the Anxiety of Schizophrenic Patients and Members of their Families, 12th International symposium for the psychotherapy of schizophrenia international conference ISPA, London, October 12-16, Collection of Lectures and Abstracts, London, (241), pp.169, 1997

183. MILOJKOVIĆ, M., MILOJKOVIĆ, Z., NIKOLIĆ, M., MUNJIZA M. (1997): Multiaxial evaluation schizoaffective disorders: five-year-study of obesrbation, 12th International symposium for the psychotherapy of schizophrenia international conference ISPA, London, October 12-16, Collection of Lectures and Abstracts, London, (217), pp.155, 1997

184 .MUNJIZA M (1998):Metereological factors and mixed and depression, 5th World Congress on “Inovation in psychiatry–” (Posters, 2003s), London,19th-22th May, Apstract Book,  pp. 89.

185. MUNJIZA, M. et al. (1998): The role of family in the quality of life and social reintegration of schizophrenic patients, Annual Coference Bulgarian Psychiatric Assotiation, Sofia, 6.-8. November 1998, Abstarcs book, p 27.

186. MUNJIZA M et al. (1998): Systemic family therapy, antidepressant treatment of alcoholism, anf quality of life in family, Annual Coference Bulgarian Psychiatric Assotiation, Sofia, 6.-8. November 1998, Abstarcs book, p 28.

187. MILOJEVIĆ, S., LJUBOMIROVIC, N., JEKIC, V., MUNJIZA M. (1998): The cost-benefit analysis of the Multiinfarct dementia and cerebrovascular diosrder treatmen with Piracetam,  Annual Coference Bulgarian Psychiatric Assotiation, Sofia, 6.-8. November 1998, Abstarcs book, p 26.

188. LJUBOMIROVIĆ N., MUNJIZA M. (1998): Pharmacotherapy of child and adolescent depression; International academy for biomedical and research and Europen Decade of Brain Research, Workshop: Novel Therapeutic Strategies in the Schizophrenic Spectrum and Mood Disorders, Venice, March 13.-14. 1998 ,

189. MUNJIZA M., VELIČKOVIĆ M., MANDIĆ D., NIKOLIĆ M., LJUBOMIROVIĆ N. (1998): Psychopharmacotherapy, group psychotherapy and sociotherapy of schizophrenia, Workshop: Novel Therapeutic Strategies in the Schizophrenic Spectrum and Mood Disorders, Venice, March 13.-14. 1998

190. MUNJIZA M. (1998): Pharmacotherapy of anxiety in schizophrenia, International academy for biomedical and research and Europen Decade of Brain Research, Workshop: Novel Therapeutic Strategies in the Schizophrenic Spectrum and Mood Disorders, Venice, March 13.-14. 1998

191. FRANIĆ A., LJUBOMIROVIĆ N., MUNJIZA M., POPOVIĆ-DEUŠIĆ S. (1998): Psychic effects of war stresses on adolescents. XVI Congress of the World Assotiation for Socila Psychiatry (WASP) - International Congress of Social Psychiatry, (FC20-Enviromental psychiatry), Vancouver, British Columbia, Canada, August 16−21

192. STARČEVIĆ V., KELIN K., MUNJIZA M. (1998): A culture-sensitive scren for neurasthenia, XVI Congress of the World Assotiation for Socila Psychiatry (WASP) - International Congress of Social Psychiatry, (FC20-Enviromental psychiatry), Vancouver, British Columbia, Canada, August 16−21

193. POPOVIĆ-DEUŠIĆ S., MUNJIZA M., VULETIĆ-PECO S., LJUBOMIROVIĆ N.(1998): Follow-up of psychotic children and adolescents, XVI Congress of the World Assotiation for Socila Psychiatry, (WASP)- International Congress of Social Psychiatry), (P 56-Health services and epidemiology), Vancouver, British Columbia, Canada August 16−21

194.  MUNJIZA M., POPOVIĆ-DEUŠIĆ S.(1998): Children of manic-depressive parents,  XVI Congress of the World Assotiation for Socila Psychiatry, (WASP)-International Congress of Social Psychiatry (P168 Psychopathology and psychotherapies), Vancouver, British Columbia, Canada August 16−21, 194

195. MUNJIZA M. (1998): The pharmacotherapy of acute confused states, XVI Congress of the World Assotiation for Socila Psychiatry, (WASP) - International Congress of Social Psychiatry (P97-Neurosciences, psychopharmacology and biological psychiatry),  (WASP), Vancouver, British Columbia, Canada, August 16−21

196. MUNJIZA M. (1998): Clinical-epidemiological study of Alzheimer and multi-infarc types od dementia, XVI Congress of the World Assotiation for Socila Psychiatry, (WASP) (WASP) - International Congress of Social Psychiatry, International Congress of Social Psychiatry, (P52-Health service and epidemiology), Vancouver, British Columbia, Canada, August 16−21

197. MILOŠEVIĆ S., LJUBOMIROVIĆ N., JEKIĆ V., MUNJIZA M. (1998): The cost-benefit analysis of the multiinfarct dementia and cardio-vascular disorders; treatment with piracetam. Economics and Mental Health, Annual Conference of Bulgarian Psychiatric Association.

198. MUNJIZA M. et al:(1998): Pharmacotherapy of Anxiety of Schizophrenia, American Psychiatric Association Annual Meeting, May 30-June 4, 1998, Toronto, Ontario, Canada, Abstracts book, 189

199. KUZMANOVIĆ S., MUNJIZA M. et al (1998): Psychiatric Morbidity in Primary Health Care of an Urban Area, American Psychiatric  Association Annual Meeting, May 30-June 4, 1998, Toronto, Ontario, Canada, Abstracts book, 217-218

200. MUNJIZA, M., LJUBOMIROVIĆ, N.(1998):Cost-effectivens of clozapine for treatment-rezistent schizophrenia, 8th CENP Central European Nuropsychopharmacological Symposium,Viena, August 28–30, 1998

201. LAPČEVIĆ D, MUNJIZA M et al (1999): Elektoconvulsive Therapy: Discrepancy between Initial Success and Duration of remission, XI World Congress of Psychiatry, Hamburg, August 6–11.1999, Abstracts Volumen II, pp. 60

202. MUNJIZA M. et al (1999): Electroconvulsive Therapy:  Dicrepancy Initial Success and Duration of Remission II, XI World Congress of Psychiatry, Hamburg, August 6–11.1999, Abstracts Volumen II, pp.209

203. MUNJIZA M. et al. (1999): Migration as a Risk Factor for Mental Health Disorders, XI World Congress of Psychiatry, Hamburg, August 6–11.1999, Abstracts Volumen II, pp.224

204. MUNJIZA M. et al (1999): The Comparative Analysis of Group Psychotherapy and Pharmacotherapy of Schizophrenia, XI World Congress of Psychiatry, Hamburg, August 6–11.1999, Abstracts Volumen II, pp. 303

205. MUNJIZA M. (1999): Effects of pharmacopsychiatry to depression in the period of adolescence, 4th ENCP Regional Meating 1999, Kraków–Poland, 17-19 April 1999.

206. MUNJIZA M. (1999): Use of psychostabililerer in the treatment of a various types of aggresion in bipolar disrders and bahavioral disorders, 12th European College of Neuropsychopharmacolog, London, UK, September 21th–25th,1999

207. MUNJIZA M. (2000): Long-term treatment of female chronic patients with neuroleptic drugs, Association of European Psychiatrists (AEP), section committee "Psychiatric Epidemiologic and Social Psychiatry, IXth European Symposium,  Abstracts book, 98., Budimpešta, April 27th-29th 2000.

208. MUNJIZA M. (2000): A cost-benfit analysis in drug therapy of depression, Association of European Psychiatrists (AEP), section committee "Psychiatric Epidemiologic and Social Psychiatry, IXth European Symposium, Abstracts book, 98. Budimpešta, April  27th-29th 2000.